Current management strategy of hepatocellular carcinoma | Zendy

Bernardino Rampone | Zendy; Beniamino Schiavone | Zendy; Antonio Martino | Zendy; Carmine Viviano | Zendy; G Confuorto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current management strategy of hepatocellular carcinoma

Author(s) -

Bernardino Rampone,

Beniamino Schiavone,

Antonio Martino,

Carmine Viviano,

G Confuorto

Publication year - 2009

Publication title -

world journal of gastroenterology

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.15.3210

Subject(s) - hepatocellular carcinoma , medicine , malignancy , liver transplantation , curative treatment , carcinoma , disease , intensive care medicine , transplantation , general surgery , surgery , oncology

Hepatocellular carcinoma (HCC) still remains a considerable challenge for surgeons. Surgery, including liver transplantation, is the most important therapeutic approach for patients with this disease. HCC is frequently diagnosed at advanced stages and has a poor prognosis with a high mortality rate even when surgical resection has been considered potentially curative. This brief report summarizes the current status of the management of this malignancy and includes a short description of new pharmacological approaches in HCC treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research